Medicus Pharma Ltd: Medicus Pharma Receives FDA "Study May Proceed" Clearance For Teverelix Phase 2b Study in Advanced Prostate Cancer Patients with High Cardiovascular Risk

Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development ...
Montrose Press

DMEA scraps solar array plan, citing cost review; rate fears, as co-op withdraws from $72 million partially forgivable PACE loan

Delta-Montrose Electric Association is bowing out of the loan forgiveness program award that would have helped build a 20 ...
Solar Power World

Oregon awards $12 million to 24 projects in community renewable energy grant program

The Oregon Dept. of Energy has selected 24 recipients to receive nearly $12 million in Community Renewable Energy Grant ...

ArrayPatch Ltd: ArrayPatch Announces First Close of €3M Seed Round to Advance ITZ-DerMap for Treatment of Nail Fungus

ArrayPatch Ltd, a biotech company developing innovative microneedle-based therapeutics, today announced the first close of its €3 million seed funding ...